Document is current
Any future updates will be listed below
-
Authors
Zhu, Yanlong http://orcid.org/0000-0003-4909-7336
Esnault, Stephane http://orcid.org/0000-0001-7238-8671
Ge, Ying http://orcid.org/0000-0001-5211-6812
Jarjour, Nizar N. http://orcid.org/0000-0003-0170-8927
Brasier, Allan R. http://orcid.org/0000-0002-5012-4090
-
Funding
Funding for this research was provided by:
National Center for Advancing Translational Sciences (UL1TR002373, UL1TR002373, UL1TR002373, UL1TR002373)
National Institute of Allergy and Infectious Diseases (U01 AI136994, U01 AI136994, U01 AI136994, U01 AI136994)
National Institutes of Health (S10 OD018475, S10 OD018475)
- License Information
-
More Information
Article History
Received: 7 December 2021
Accepted: 4 April 2022
First Online: 19 May 2022
Declarations
:
: As noted in the Methods, this is a controlled human challenge without therapeutic intervention. All subjects participated by informed, written consent. The inclusion and exclusion criteria for the study has been previously reported [CitationRef removed]. The study was approved and received oversight by the University of Wisconsin-Madison Institutional Review Board (IRB: H-2007-0311/2013-0838). There were no animals used in this study.
: Not applicable.
: YZ, YG, ARB declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
